90. Surg Clin North Am. 2018 Aug;98(4):787-800. doi: 10.1016/j.suc.2018.03.009. Epub 2018 May 24.Inflammatory Breast Cancer: What to Know About This Unique, Aggressive BreastCancer.Menta A(1), Fouad TM(2), Lucci A(3), Le-Petross H(4), Stauder MC(5), WoodwardWA(5), Ueno NT(6), Lim B(7).Author information: (1)The University of Texas at Austin, 110 Inner Campus Drive, Austin, TX 78705,USA.(2)Morgan Welch Inflammatory Breast Cancer Research and Clinic Program, TheUniversity of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Department of Medical Oncology, The National Cancer Institute,Cairo University, Cairo 11796, Egypt.(3)Morgan Welch Inflammatory Breast Cancer Research and Clinic Program, TheUniversity of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Breast Surgical Oncology, The University of Texas MD AndersonCancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.(4)Morgan Welch Inflammatory Breast Cancer Research and Clinic Program, TheUniversity of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Breast Diagnostic Imaging, The University of Texas MD AndersonCancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.(5)Morgan Welch Inflammatory Breast Cancer Research and Clinic Program, TheUniversity of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Radiation Oncology, The University of Texas MD Anderson CancerCenter, 1515 Holcombe Boulevard, Houston, TX 77030, USA.(6)Morgan Welch Inflammatory Breast Cancer Research and Clinic Program, TheUniversity of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Breast Medical Oncology, The University of Texas MD AndersonCancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.(7)Morgan Welch Inflammatory Breast Cancer Research and Clinic Program, TheUniversity of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Breast Medical Oncology, The University of Texas MD AndersonCancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronicaddress: blim@mdanderson.org.Inflammatory breast cancer (IBC) is a rare form of breast cancer that accountsfor only 2% to 4% of all breast cancer cases. Despite its low incidence, IBCcontributes to 7% to 10% of breast cancer caused mortality. Despite ongoinginternational efforts to formulate better diagnosis, treatment, and research, thesurvival of patients with IBC has not been significantly improved, and there are no therapeutic agents that specifically target IBC to date. The authors present acomprehensive overview that aims to assess the present and new managementstrategies of IBC.Copyright Â© 2018 Elsevier Inc. All rights reserved.DOI: 10.1016/j.suc.2018.03.009 PMID: 30005774  [Indexed for MEDLINE]